Brooks Laboratories Announces Withdrawal from Proposed Scheme of Arrangement
Brooks Laboratories Limited announced an update regarding the Scheme of Arrangement involving Brooks Steriscience Limited (BSL). In a statement released on May 14, 2026, the company confirmed that BSL has decided not to proceed with the proposed transaction in its current form.The announcement follows earlier information provided on February 6, 2026, concerning an in-principle approval received from The National Stock Exchange of India Limited and BSE Limited. This approval related to a proposed composite scheme of arrangement and amalgamation (merger by absorption) among several entities: Steriscience Speciales Private Limited, Brooks Steriscience Limited, Steriscience Pte. Limited, Strides Pharma Services Private Limited, and Onesource Specialty Pharma Limited.
According to the update, Brooks Steriscience Limited held a board meeting on May 14, 2026, where the proposed transaction was deliberated. Following the meeting, BSL concluded that, in the best interest of all stakeholders, the company would not be pursuing the transaction in its current form.
BROOKS Stock Price Movement
Today, Brooks Laboratories Limited shares edged higher, closing at ₹48.47, representing a gain of 1.66%. The stock saw active trading during the session, with 21,148 shares recorded in volume.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.